Correlation Between BioXcel Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioXcel Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioXcel Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioXcel Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on BioXcel Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioXcel Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioXcel Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for BioXcel Therapeutics and Hepion Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between BioXcel and Hepion is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding BioXcel Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and BioXcel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioXcel Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of BioXcel Therapeutics i.e., BioXcel Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioXcel Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days BioXcel Therapeutics is expected to generate 1.22 times more return on investment than Hepion Pharmaceuticals. However, BioXcel Therapeutics is 1.22 times more volatile than Hepion Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 32.00 in BioXcel Therapeutics on October 20, 2024 and sell it today you would earn a total of 2.00 from holding BioXcel Therapeutics or generate 6.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
BioXcel Therapeutics vs. Hepion Pharmaceuticals
Performance |
Timeline |
BioXcel Therapeutics |
Hepion Pharmaceuticals |
BioXcel Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioXcel Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite BioXcel Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioXcel Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance |